Ignite Creation Date:
2024-06-16 @ 11:51 AM
Last Modification Date:
2024-10-26 @ 3:31 PM
Study NCT ID:
NCT06450366
Status:
RECRUITING
Last Update Posted:
2024-06-10
First Post:
2024-06-04
Brief Title:
A Study to Evaluate the Efficacy and Safety of Enlicitide Decanoate MK-0616 Oral PCSK9 Inhibitor Compared With Ezetimibe or Bempedoic Acid or Ezetimibe and Bempedoic Acid in Adults With Hypercholesterolemia MK-0616-018 CORALreef AddOn
Sponsor:
Merck Sharp Dohme LLC
Organization:
Merck Sharp Dohme LLC
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-07-15
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-07-21
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-09-22
Completion Date Type:
ESTIMATED
First Submit Date:
2024-06-04
First Submit QC Date:
June 4 2024
Study First Post Date:
2024-06-10
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-09-27
Last Update Post Date:
2024-06-10
Last Update Post Date Type:
ACTUAL